Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
This report aims to provide a comprehensive study of the global market for Prilide Antihypertensive Drugs.
Report Highlights:
(1) Global Prilide Antihypertensive Drugs market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Prilide Antihypertensive Drugs market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Prilide Antihypertensive Drugs market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Prilide Antihypertensive Drugs segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Prilide Antihypertensive Drugs segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Prilide Antihypertensive Drugs, capacity, production and trends.
(7) Prilide Antihypertensive Drugs industry supply chain, upstream, midstream and downstream analysis.
According to Latest Research, the global market for Prilide Antihypertensive Drugs should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Prilide Antihypertensive Drugs market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Prilide Antihypertensive Drugs market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Captopril segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Prilide Antihypertensive Drugs include Merck, Pfizer, Sanofi, Abbott, Novartis, Changzhou Pharmaceutical, Humanwell Pharmaceutical, Hengcheng Pharmaceutical and Hengwei Pharmaceutical, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
By Product Type, the market is primarily segmented into:
Captopril
Enalapril
Lisinopril
Fosinopril
Others
By Applications, the market is segmented into:
Hospital
Clinic
Key Players Driving the Market:
Merck
Pfizer
Sanofi
Abbott
Novartis
Changzhou Pharmaceutical
Humanwell Pharmaceutical
Hengcheng Pharmaceutical
Hengwei Pharmaceutical
Zhongfu Pharmaceutical
Likang Pharmaceutical
Changjiang Pharmaceutical
Baiyunshan Pharmaceutical
Poly Pharm
Lukang Group
Baili Pharmaceutical
Huahai Pharmaceutical
1 Market Overview
1.1 Prilide Antihypertensive Drugs Definition
1.2 Global Prilide Antihypertensive Drugs Market Size and Forecast
1.2.1 By Revenue, Global Prilide Antihypertensive Drugs Market Size, 2018-2029
1.2.2 By Sales Volume, Global Prilide Antihypertensive Drugs Market Size, 2018-2029
1.2.3 Global Prilide Antihypertensive Drugs Price Trend, 2018-2029
1.3 China Prilide Antihypertensive Drugs Market Size and Forecast
1.3.1 By Revenue, China Prilide Antihypertensive Drugs Market Size, 2018-2029
1.3.2 By Sales Volume, China Prilide Antihypertensive Drugs Market Size, 2018-2029
1.3.3 China Prilide Antihypertensive Drugs Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Prilide Antihypertensive Drugs Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Prilide Antihypertensive Drugs Share in Global Market, 2018-2029
1.4.3 Prilide Antihypertensive Drugs Market Size: China VS Global, 2018-2029
1.5 Prilide Antihypertensive Drugs Market Dynamics
1.5.1 Prilide Antihypertensive Drugs Market Drivers
1.5.2 Prilide Antihypertensive Drugs Market Restraints
1.5.3 Prilide Antihypertensive Drugs Industry Trends
1.5.4 Prilide Antihypertensive Drugs Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Prilide Antihypertensive Drugs Revenue by Company, 2018-2023
2.2 Global Prilide Antihypertensive Drugs Sales Volume by Company, 2018-2023
2.3 Global Prilide Antihypertensive Drugs Price by Company, 2018-2023
2.4 Global Prilide Antihypertensive Drugs Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Prilide Antihypertensive Drugs Concentration Ratio
2.6 Global Prilide Antihypertensive Drugs Mergers & Acquisitions, Expansion Plans
2.7 Global Prilide Antihypertensive Drugs Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Prilide Antihypertensive Drugs Revenue by Company, 2018-2023
3.2 China Prilide Antihypertensive Drugs Sales Volume by Company, 2018-2023
3.3 China Prilide Antihypertensive Drugs Prilide Antihypertensive Drugs Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Prilide Antihypertensive Drugs Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Prilide Antihypertensive Drugs Domestic VS Export
3.6 China Market, Prilide Antihypertensive Drugs Import & Export
3.6.1 China Market, Prilide Antihypertensive Drugs Import & Export, 2018-2029
3.6.2 China Prilide Antihypertensive Drugs Import & Export Trends
3.6.3 Main Sources of China Prilide Antihypertensive Drugs Import
3.6.4 Export Destination of China Prilide Antihypertensive Drugs
4 Prilide Antihypertensive Drugs Production by Region
4.1 Global Prilide Antihypertensive Drugs Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Prilide Antihypertensive Drugs Manufacturers
4.3 Global Major Manufacturers, Prilide Antihypertensive Drugs Capacity Expansion and Future Plans
4.4 Global Prilide Antihypertensive Drugs Capacity by Region
4.5 Global Prilide Antihypertensive Drugs Production by Region
4.5.1 Global Prilide Antihypertensive Drugs Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Prilide Antihypertensive Drugs Production by Region, 2018-2023
4.5.3 Global Prilide Antihypertensive Drugs Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Prilide Antihypertensive Drugs Industry Chain
5.2 Prilide Antihypertensive Drugs Upstream Analysis
5.2.1 Prilide Antihypertensive Drugs Core Raw Materials
5.2.2 Main Manufacturers of Prilide Antihypertensive Drugs Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Prilide Antihypertensive Drugs Production Mode
5.6 Prilide Antihypertensive Drugs Procurement Model
5.7 Prilide Antihypertensive Drugs Industry Sales Model and Sales Channels
5.7.1 Prilide Antihypertensive Drugs Sales Model
5.7.2 Prilide Antihypertensive Drugs Typical Distributors
6 Sights by Type
6.1 Prilide Antihypertensive Drugs Classification
6.1.1 Captopril
6.1.2 Enalapril
6.1.3 Lisinopril
6.1.4 Fosinopril
6.1.5 Others
6.2 By Type, Global Prilide Antihypertensive Drugs Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Prilide Antihypertensive Drugs Revenue, 2018-2029
6.4 By Type, Global Prilide Antihypertensive Drugs Sales Volume, 2018-2029
6.5 By Type, Global Prilide Antihypertensive Drugs Price, 2018-2029
7 Sights by Application
7.1 Prilide Antihypertensive Drugs Segment by Application
7.1.1 Hospital
7.1.2 Clinic
7.2 By Application, Global Prilide Antihypertensive Drugs Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Prilide Antihypertensive Drugs Revenue, 2018-2029
7.4 By Application, Global Prilide Antihypertensive Drugs Sales Volume, 2018-2029
7.5 By Application, Global Prilide Antihypertensive Drugs Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Prilide Antihypertensive Drugs Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Prilide Antihypertensive Drugs Revenue, 2018-2029
8.3 By Region, Global Prilide Antihypertensive Drugs Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Prilide Antihypertensive Drugs Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Prilide Antihypertensive Drugs Market Size Market Share
8.5 Europe
8.5.1 Europe Prilide Antihypertensive Drugs Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Prilide Antihypertensive Drugs Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Prilide Antihypertensive Drugs Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Prilide Antihypertensive Drugs Market Size Market Share
8.7 South America
8.7.1 South America Prilide Antihypertensive Drugs Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Prilide Antihypertensive Drugs Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Prilide Antihypertensive Drugs Market Size & CAGR,2018 VS 2022 VS 2029
9.2 By Country, Global Prilide Antihypertensive Drugs Revenue, 2018-2029
9.3 By Country, Global Prilide Antihypertensive Drugs Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Prilide Antihypertensive Drugs Market Size, 2018-2029
9.4.2 By Company, U.S. Prilide Antihypertensive Drugs Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Prilide Antihypertensive Drugs Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Prilide Antihypertensive Drugs Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Prilide Antihypertensive Drugs Market Size, 2018-2029
9.5.2 By Company, Europe Prilide Antihypertensive Drugs Sales Volume Market Share, 2022
9.5.3 By Type, Europe Prilide Antihypertensive Drugs Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Prilide Antihypertensive Drugs Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Prilide Antihypertensive Drugs Market Size, 2018-2029
9.6.2 By Company, China Prilide Antihypertensive Drugs Sales Volume Market Share, 2022
9.6.3 By Type, China Prilide Antihypertensive Drugs Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Prilide Antihypertensive Drugs Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Prilide Antihypertensive Drugs Market Size, 2018-2029
9.7.2 By Company, Japan Prilide Antihypertensive Drugs Sales Volume Market Share, 2022
9.7.3 By Type, Japan Prilide Antihypertensive Drugs Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Prilide Antihypertensive Drugs Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Prilide Antihypertensive Drugs Market Size, 2018-2029
9.8.2 By Company, South Korea Prilide Antihypertensive Drugs Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Prilide Antihypertensive Drugs Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Prilide Antihypertensive Drugs Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Prilide Antihypertensive Drugs Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Prilide Antihypertensive Drugs Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Prilide Antihypertensive Drugs Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Prilide Antihypertensive Drugs Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Prilide Antihypertensive Drugs Market Size, 2018-2029
9.10.2 By Company, India Prilide Antihypertensive Drugs Sales Volume Market Share, 2022
9.10.3 By Type, India Prilide Antihypertensive Drugs Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Prilide Antihypertensive Drugs Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Prilide Antihypertensive Drugs Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Prilide Antihypertensive Drugs Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Prilide Antihypertensive Drugs Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Prilide Antihypertensive Drugs Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Merck
10.1.1 Merck Company Information, Head Office, Market Area and Industry Position
10.1.2 Merck Prilide Antihypertensive Drugs Models, Specifications and Application
10.1.3 Merck Prilide Antihypertensive Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Merck Company Profile and Main Business
10.1.5 Merck Recent Developments
10.2 Pfizer
10.2.1 Pfizer Company Information, Head Office, Market Area and Industry Position
10.2.2 Pfizer Prilide Antihypertensive Drugs Models, Specifications and Application
10.2.3 Pfizer Prilide Antihypertensive Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Pfizer Company Profile and Main Business
10.2.5 Pfizer Recent Developments
10.3 Sanofi
10.3.1 Sanofi Company Information, Head Office, Market Area and Industry Position
10.3.2 Sanofi Prilide Antihypertensive Drugs Models, Specifications and Application
10.3.3 Sanofi Prilide Antihypertensive Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Sanofi Company Profile and Main Business
10.3.5 Sanofi Recent Developments
10.4 Abbott
10.4.1 Abbott Company Information, Head Office, Market Area and Industry Position
10.4.2 Abbott Prilide Antihypertensive Drugs Models, Specifications and Application
10.4.3 Abbott Prilide Antihypertensive Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Abbott Company Profile and Main Business
10.4.5 Abbott Recent Developments
10.5 Novartis
10.5.1 Novartis Company Information, Head Office, Market Area and Industry Position
10.5.2 Novartis Prilide Antihypertensive Drugs Models, Specifications and Application
10.5.3 Novartis Prilide Antihypertensive Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Novartis Company Profile and Main Business
10.5.5 Novartis Recent Developments
10.6 Changzhou Pharmaceutical
10.6.1 Changzhou Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.6.2 Changzhou Pharmaceutical Prilide Antihypertensive Drugs Models, Specifications and Application
10.6.3 Changzhou Pharmaceutical Prilide Antihypertensive Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Changzhou Pharmaceutical Company Profile and Main Business
10.6.5 Changzhou Pharmaceutical Recent Developments
10.7 Humanwell Pharmaceutical
10.7.1 Humanwell Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.7.2 Humanwell Pharmaceutical Prilide Antihypertensive Drugs Models, Specifications and Application
10.7.3 Humanwell Pharmaceutical Prilide Antihypertensive Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Humanwell Pharmaceutical Company Profile and Main Business
10.7.5 Humanwell Pharmaceutical Recent Developments
10.8 Hengcheng Pharmaceutical
10.8.1 Hengcheng Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.8.2 Hengcheng Pharmaceutical Prilide Antihypertensive Drugs Models, Specifications and Application
10.8.3 Hengcheng Pharmaceutical Prilide Antihypertensive Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Hengcheng Pharmaceutical Company Profile and Main Business
10.8.5 Hengcheng Pharmaceutical Recent Developments
10.9 Hengwei Pharmaceutical
10.9.1 Hengwei Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.9.2 Hengwei Pharmaceutical Prilide Antihypertensive Drugs Models, Specifications and Application
10.9.3 Hengwei Pharmaceutical Prilide Antihypertensive Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Hengwei Pharmaceutical Company Profile and Main Business
10.9.5 Hengwei Pharmaceutical Recent Developments
10.10 Zhongfu Pharmaceutical
10.10.1 Zhongfu Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.10.2 Zhongfu Pharmaceutical Prilide Antihypertensive Drugs Models, Specifications and Application
10.10.3 Zhongfu Pharmaceutical Prilide Antihypertensive Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Zhongfu Pharmaceutical Company Profile and Main Business
10.10.5 Zhongfu Pharmaceutical Recent Developments
10.11 Likang Pharmaceutical
10.11.1 Likang Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.11.2 Likang Pharmaceutical Prilide Antihypertensive Drugs Models, Specifications and Application
10.11.3 Likang Pharmaceutical Prilide Antihypertensive Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Likang Pharmaceutical Company Profile and Main Business
10.11.5 Likang Pharmaceutical Recent Developments
10.12 Changjiang Pharmaceutical
10.12.1 Changjiang Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.12.2 Changjiang Pharmaceutical Prilide Antihypertensive Drugs Models, Specifications and Application
10.12.3 Changjiang Pharmaceutical Prilide Antihypertensive Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Changjiang Pharmaceutical Company Profile and Main Business
10.12.5 Changjiang Pharmaceutical Recent Developments
10.13 Baiyunshan Pharmaceutical
10.13.1 Baiyunshan Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.13.2 Baiyunshan Pharmaceutical Prilide Antihypertensive Drugs Models, Specifications and Application
10.13.3 Baiyunshan Pharmaceutical Prilide Antihypertensive Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Baiyunshan Pharmaceutical Company Profile and Main Business
10.13.5 Baiyunshan Pharmaceutical Recent Developments
10.14 Poly Pharm
10.14.1 Poly Pharm Company Information, Head Office, Market Area and Industry Position
10.14.2 Poly Pharm Prilide Antihypertensive Drugs Models, Specifications and Application
10.14.3 Poly Pharm Prilide Antihypertensive Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Poly Pharm Company Profile and Main Business
10.14.5 Poly Pharm Recent Developments
10.15 Lukang Group
10.15.1 Lukang Group Company Information, Head Office, Market Area and Industry Position
10.15.2 Lukang Group Prilide Antihypertensive Drugs Models, Specifications and Application
10.15.3 Lukang Group Prilide Antihypertensive Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Lukang Group Company Profile and Main Business
10.15.5 Lukang Group Recent Developments
10.16 Baili Pharmaceutical
10.16.1 Baili Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.16.2 Baili Pharmaceutical Prilide Antihypertensive Drugs Models, Specifications and Application
10.16.3 Baili Pharmaceutical Prilide Antihypertensive Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.16.4 Baili Pharmaceutical Company Profile and Main Business
10.16.5 Baili Pharmaceutical Recent Developments
10.17 Huahai Pharmaceutical
10.17.1 Huahai Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.17.2 Huahai Pharmaceutical Prilide Antihypertensive Drugs Models, Specifications and Application
10.17.3 Huahai Pharmaceutical Prilide Antihypertensive Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.17.4 Huahai Pharmaceutical Company Profile and Main Business
10.17.5 Huahai Pharmaceutical Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Tables & Figures:
Table 1. Prilide Antihypertensive Drugs Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Prilide Antihypertensive Drugs Market Restraints
Table 3. Prilide Antihypertensive Drugs Market Trends
Table 4. Prilide Antihypertensive Drugs Industry Policy
Table 5. Global Prilide Antihypertensive Drugs Revenue by Company, 2018-2023, US$ million
Table 6. Global Prilide Antihypertensive Drugs Revenue Market Share by Company, 2018-2023
Table 7. Global Prilide Antihypertensive Drugs Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Prilide Antihypertensive Drugs Sales Volume Market Share by Company, 2018-2023
Table 9. Global Prilide Antihypertensive Drugs Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Prilide Antihypertensive Drugs Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Prilide Antihypertensive Drugs Mergers & Acquisitions, Expansion Plans
Table 12. Global Prilide Antihypertensive Drugs Manufacturers Product Type
Table 13. China Prilide Antihypertensive Drugs Revenue by Company, 2018-2023, US$ million
Table 14. China Prilide Antihypertensive Drugs Revenue Market Share by Company, 2018-2023
Table 15. China Prilide Antihypertensive Drugs Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Prilide Antihypertensive Drugs Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Prilide Antihypertensive Drugs Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Prilide Antihypertensive Drugs Import & Export Trends
Table 19. Main Sources of China Prilide Antihypertensive Drugs Import
Table 20. Export Destination of China Prilide Antihypertensive Drugs
Table 21. Global Headquarters and Manufacturing Base of Prilide Antihypertensive Drugs Manufacturers
Table 22. Global Major Manufacturers, Prilide Antihypertensive Drugs Capacity Expansion and Future Plans
Table 23. Global Prilide Antihypertensive Drugs Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Prilide Antihypertensive Drugs Production by Region, 2018-2023, (K Units)
Table 25. Global Prilide Antihypertensive Drugs Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Prilide Antihypertensive Drugs Upstream (Raw Materials)
Table 27. Global Prilide Antihypertensive Drugs Typical Customers
Table 28. Prilide Antihypertensive Drugs Typical Distributors
Table 29. By Type, Global Prilide Antihypertensive Drugs Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Prilide Antihypertensive Drugs Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Prilide Antihypertensive Drugs Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Prilide Antihypertensive Drugs Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Prilide Antihypertensive Drugs Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Prilide Antihypertensive Drugs Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Prilide Antihypertensive Drugs Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Prilide Antihypertensive Drugs Revenue Market Share, 2018-2029
Table 37. By Country, Global Prilide Antihypertensive Drugs Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Prilide Antihypertensive Drugs Sales Volume Market Share, 2018-2029
Table 39. Merck Company Information, Head Office, Market Area and Industry Position
Table 40. Merck Prilide Antihypertensive Drugs Models, Specifications and Application
Table 41. Merck Prilide Antihypertensive Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Merck Company Profile and Main Business
Table 43. Merck Recent Developments
Table 44. Pfizer Company Information, Head Office, Market Area and Industry Position
Table 45. Pfizer Prilide Antihypertensive Drugs Models, Specifications and Application
Table 46. Pfizer Prilide Antihypertensive Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Pfizer Company Profile and Main Business
Table 48. Pfizer Recent Developments
Table 49. Sanofi Company Information, Head Office, Market Area and Industry Position
Table 50. Sanofi Prilide Antihypertensive Drugs Models, Specifications and Application
Table 51. Sanofi Prilide Antihypertensive Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Sanofi Company Profile and Main Business
Table 53. Sanofi Recent Developments
Table 54. Abbott Company Information, Head Office, Market Area and Industry Position
Table 55. Abbott Prilide Antihypertensive Drugs Models, Specifications and Application
Table 56. Abbott Prilide Antihypertensive Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Abbott Company Profile and Main Business
Table 58. Abbott Recent Developments
Table 59. Novartis Company Information, Head Office, Market Area and Industry Position
Table 60. Novartis Prilide Antihypertensive Drugs Models, Specifications and Application
Table 61. Novartis Prilide Antihypertensive Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Novartis Company Profile and Main Business
Table 63. Novartis Recent Developments
Table 64. Changzhou Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 65. Changzhou Pharmaceutical Prilide Antihypertensive Drugs Models, Specifications and Application
Table 66. Changzhou Pharmaceutical Prilide Antihypertensive Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Changzhou Pharmaceutical Company Profile and Main Business
Table 68. Changzhou Pharmaceutical Recent Developments
Table 69. Humanwell Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 70. Humanwell Pharmaceutical Prilide Antihypertensive Drugs Models, Specifications and Application
Table 71. Humanwell Pharmaceutical Prilide Antihypertensive Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Humanwell Pharmaceutical Company Profile and Main Business
Table 73. Humanwell Pharmaceutical Recent Developments
Table 74. Hengcheng Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 75. Hengcheng Pharmaceutical Prilide Antihypertensive Drugs Models, Specifications and Application
Table 76. Hengcheng Pharmaceutical Prilide Antihypertensive Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Hengcheng Pharmaceutical Company Profile and Main Business
Table 78. Hengcheng Pharmaceutical Recent Developments
Table 79. Hengwei Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 80. Hengwei Pharmaceutical Prilide Antihypertensive Drugs Models, Specifications and Application
Table 81. Hengwei Pharmaceutical Prilide Antihypertensive Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Hengwei Pharmaceutical Company Profile and Main Business
Table 83. Hengwei Pharmaceutical Recent Developments
Table 84. Zhongfu Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 85. Zhongfu Pharmaceutical Prilide Antihypertensive Drugs Models, Specifications and Application
Table 86. Zhongfu Pharmaceutical Prilide Antihypertensive Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Zhongfu Pharmaceutical Company Profile and Main Business
Table 88. Zhongfu Pharmaceutical Recent Developments
Table 89. Likang Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 90. Likang Pharmaceutical Prilide Antihypertensive Drugs Models, Specifications and Application
Table 91. Likang Pharmaceutical Prilide Antihypertensive Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Likang Pharmaceutical Company Profile and Main Business
Table 93. Likang Pharmaceutical Recent Developments
Table 94. Changjiang Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 95. Changjiang Pharmaceutical Prilide Antihypertensive Drugs Models, Specifications and Application
Table 96. Changjiang Pharmaceutical Prilide Antihypertensive Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Changjiang Pharmaceutical Company Profile and Main Business
Table 98. Changjiang Pharmaceutical Recent Developments
Table 99. Baiyunshan Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 100. Baiyunshan Pharmaceutical Prilide Antihypertensive Drugs Models, Specifications and Application
Table 101. Baiyunshan Pharmaceutical Prilide Antihypertensive Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Baiyunshan Pharmaceutical Company Profile and Main Business
Table 103. Baiyunshan Pharmaceutical Recent Developments
Table 104. Poly Pharm Company Information, Head Office, Market Area and Industry Position
Table 105. Poly Pharm Prilide Antihypertensive Drugs Models, Specifications and Application
Table 106. Poly Pharm Prilide Antihypertensive Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Poly Pharm Company Profile and Main Business
Table 108. Poly Pharm Recent Developments
Table 109. Lukang Group Company Information, Head Office, Market Area and Industry Position
Table 110. Lukang Group Prilide Antihypertensive Drugs Models, Specifications and Application
Table 111. Lukang Group Prilide Antihypertensive Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. Lukang Group Company Profile and Main Business
Table 113. Lukang Group Recent Developments
Table 114. Baili Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 115. Baili Pharmaceutical Prilide Antihypertensive Drugs Models, Specifications and Application
Table 116. Baili Pharmaceutical Prilide Antihypertensive Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 117. Baili Pharmaceutical Company Profile and Main Business
Table 118. Baili Pharmaceutical Recent Developments
Table 119. Huahai Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 120. Huahai Pharmaceutical Prilide Antihypertensive Drugs Models, Specifications and Application
Table 121. Huahai Pharmaceutical Prilide Antihypertensive Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 122. Huahai Pharmaceutical Company Profile and Main Business
Table 123. Huahai Pharmaceutical Recent Developments
List of Figure
Figure 1. Prilide Antihypertensive Drugs Picture
Figure 2. By Revenue, Global Prilide Antihypertensive Drugs Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Prilide Antihypertensive Drugs Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Prilide Antihypertensive Drugs Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Prilide Antihypertensive Drugs Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Prilide Antihypertensive Drugs Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Prilide Antihypertensive Drugs Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Prilide Antihypertensive Drugs Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Prilide Antihypertensive Drugs Share of Global Market, 2018-2029
Figure 10. Global Prilide Antihypertensive Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Prilide Antihypertensive Drugs Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Prilide Antihypertensive Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Prilide Antihypertensive Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Prilide Antihypertensive Drugs Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Prilide Antihypertensive Drugs Domestic VS Export, 2022
Figure 16. Global Prilide Antihypertensive Drugs Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Prilide Antihypertensive Drugs Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Prilide Antihypertensive Drugs Production Market Share & Forecast by Region, 2018-2029
Figure 19. Prilide Antihypertensive Drugs Industry Chain
Figure 20. Prilide Antihypertensive Drugs Procurement Model
Figure 21. Prilide Antihypertensive Drugs Sales Model
Figure 22. Prilide Antihypertensive Drugs Sales Channels, Direct Sales and Distribution
Figure 23. Captopril
Figure 24. Enalapril
Figure 25. Lisinopril
Figure 26. Fosinopril
Figure 27. Others
Figure 28. By Type, Global Prilide Antihypertensive Drugs Revenue, 2018-2029, US$ Million
Figure 29. By Type, Global Prilide Antihypertensive Drugs Revenue Market Share, 2018-2029
Figure 30. By Type, Global Prilide Antihypertensive Drugs Sales Volume, 2018-2029, (K Units)
Figure 31. By Type, Global Prilide Antihypertensive Drugs Sales Volume Market Share, 2018-2029
Figure 32. By Type, Global Prilide Antihypertensive Drugs Price, 2018-2029, (US$/Unit)
Figure 33. Hospital
Figure 34. Clinic
Figure 35. By Application, Global Prilide Antihypertensive Drugs Revenue, 2018-2029, US$ Million
Figure 36. By Application, Global Prilide Antihypertensive Drugs Revenue Market Share, 2018-2029
Figure 37. By Application, Global Prilide Antihypertensive Drugs Sales Volume, 2018-2029, (K Units)
Figure 38. By Application, Global Prilide Antihypertensive Drugs Sales Volume Market Share, 2018-2029
Figure 39. By Application, Global Prilide Antihypertensive Drugs Price, 2018-2029, (US$/Unit)
Figure 40. By Region, Global Prilide Antihypertensive Drugs Revenue Market Share, 2018-2029
Figure 41. By Region, Global Prilide Antihypertensive Drugs Sales Volume Market Share, 2018-2029
Figure 42. North America Prilide Antihypertensive Drugs Revenue & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, North America Prilide Antihypertensive Drugs Revenue Market Share, 2022
Figure 44. Europe Prilide Antihypertensive Drugs Revenue & Forecasts, 2018-2029, US$ Million
Figure 45. By Country, Europe Prilide Antihypertensive Drugs Revenue Market Share, 2022
Figure 46. Asia Pacific Prilide Antihypertensive Drugs Revenue & Forecasts, 2018-2029, US$ Million
Figure 47. By Country/Region, Asia Pacific Prilide Antihypertensive Drugs Revenue Market Share, 2022
Figure 48. South America Prilide Antihypertensive Drugs Revenue & Forecasts, 2018-2029, US$ Million
Figure 49. By Country, South America Prilide Antihypertensive Drugs Revenue Market Share, 2022
Figure 50. Middle East & Africa Prilide Antihypertensive Drugs Revenue & Forecasts, 2018-2029, US$ Million
Figure 51. U.S. Prilide Antihypertensive Drugs Sales Volume, 2018-2029, (K Units)
Figure 52. By Company, U.S. Prilide Antihypertensive Drugs Market Share, 2022
Figure 53. By Type, U.S. Prilide Antihypertensive Drugs Sales Volume Market Share, 2022 VS 2029
Figure 54. By Application, U.S. Prilide Antihypertensive Drugs Sales Volume Market Share, 2022 VS 2029
Figure 55. Europe Prilide Antihypertensive Drugs Sales Volume, 2018-2029, (K Units)
Figure 56. By Company, Europe Prilide Antihypertensive Drugs Market Share, 2022
Figure 57. By Type, Europe Prilide Antihypertensive Drugs Sales Volume Market Share, 2022 VS 2029
Figure 58. By Application, Europe Prilide Antihypertensive Drugs Sales Volume Market Share, 2022 VS 2029
Figure 59. China Prilide Antihypertensive Drugs Sales Volume, 2018-2029, (K Units)
Figure 60. By Company, China Prilide Antihypertensive Drugs Market Share, 2022
Figure 61. By Type, China Prilide Antihypertensive Drugs Sales Volume Market Share, 2022 VS 2029
Figure 62. By Application, China Prilide Antihypertensive Drugs Sales Volume Market Share, 2022 VS 2029
Figure 63. Japan Prilide Antihypertensive Drugs Sales Volume, 2018-2029, (K Units)
Figure 64. By Company, Japan Prilide Antihypertensive Drugs Market Share, 2022
Figure 65. By Type, Japan Prilide Antihypertensive Drugs Sales Volume Market Share, 2022 VS 2029
Figure 66. By Application, Japan Prilide Antihypertensive Drugs Sales Volume Market Share, 2022 VS 2029
Figure 67. South Korea Prilide Antihypertensive Drugs Sales Volume, 2018-2029, (K Units)
Figure 68. By Company, South Korea Prilide Antihypertensive Drugs Market Share, 2022
Figure 69. By Type, South Korea Prilide Antihypertensive Drugs Sales Volume Market Share, 2022 VS 2029
Figure 70. By Application, South Korea Prilide Antihypertensive Drugs Sales Volume Market Share, 2022 VS 2029
Figure 71. Southeast Asia Prilide Antihypertensive Drugs Sales Volume, 2018-2029, (K Units)
Figure 72. By Company, Southeast Asia Prilide Antihypertensive Drugs Market Share, 2022
Figure 73. By Type, Southeast Asia Prilide Antihypertensive Drugs Sales Volume Market Share, 2022 VS 2029
Figure 74. By Application, Southeast Asia Prilide Antihypertensive Drugs Sales Volume Market Share, 2022 VS 2029
Figure 75. India Prilide Antihypertensive Drugs Sales Volume, 2018-2029, (K Units)
Figure 76. By Company, India Prilide Antihypertensive Drugs Market Share, 2022
Figure 77. By Type, India Prilide Antihypertensive Drugs Sales Volume Market Share, 2022 VS 2029
Figure 78. By Application, India Prilide Antihypertensive Drugs Sales Volume Market Share, 2022 VS 2029
Figure 79. Middle East & Asia Prilide Antihypertensive Drugs Sales Volume, 2018-2029, (K Units)
Figure 80. By Company, Middle East & Asia Prilide Antihypertensive Drugs Market Share, 2022
Figure 81. By Type, Middle East & Asia Prilide Antihypertensive Drugs Sales Volume Market Share, 2022 VS 2029
Figure 82. By Application, Middle East & Asia Prilide Antihypertensive Drugs Sales Volume Market Share, 2022 VS 2029
Figure 83. Research Methodology
Figure 84. Breakdown of Primary Interviews
Figure 85. Bottom-up Approaches
Figure 86. Top-down Approaches
Research Methodology:
Global Prilide Antihypertensive Drugs Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|